Studies with the azoxymethane-rat preclinical model for assessing colon tumor development and chemoprevention

Environmental and Molecular Mutagenesis

Volumn 44, Issue 1, 2004, Pages 26-35

  Reddy, Bandaru S ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

Chemoprevention; Colon cancer; Combination of chemopreventive agents; COX 2 inhibitors; Nonsteroidal antiinflammatory drugs; Omega 3 fatty acids

Indexed keywords

ACETYLSALICYLIC ACID; AZOXYMETHANE; CURCUMIN; CYCLOOXYGENASE 2 INHIBITOR; EFLORNITHINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; PIROXICAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER PREVENTION; CANCER RISK; CANCER SURVIVAL; CHEMOPROPHYLAXIS; COLON TUMOR; CONFERENCE PAPER; CONTROLLED STUDY; DIETARY INTAKE; HISTOPATHOLOGY; MALIGNANT TRANSFORMATION; MOLECULAR BIOLOGY; NONHUMAN; RAT; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TUMOR GROWTH;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AZOXYMETHANE; CHEMOPREVENTION; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EFLORNITHINE; FATTY ACIDS, OMEGA-3; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ISOENZYMES; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; PIROXICAM; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RISK ASSESSMENT;

ANIMALIA;

EID: 3242804439     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.20026     Document Type: Conference Paper

References (73)

1. Agarwal B, Rao CV, Bhendwal S, Ramey WR, Shirin H, Reddy BS, Holt PR. 1999. Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potential chemopreventive effects of sulindac. Gastroenterology 177:838-847.
2. Anti M, Armelao F, Marra G. 1994. Effect of different doses of fish oil on rectal cell proliferation in patients with sporadic colonic adenomas. Gastroenterology 107:1709-1718.
3. Bird R. 1995. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 93:55-71.
4. Brabletz T, Herrmann K, Jung A, Faller G, Kirchner T. 2000. Expression of nuclear β-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am J Pathol 156:865-870.
5. Bull AW, Soullier BK, Wilson PS, Hayden MT, Nigro ND. 1979. Promotion of azoxymethane-induced intestinal cancer by high fat diets in rats. Cancer Res 39:4956-4959.
6. Caderni G, DeFillippo D, Luceri C. 1997. APC mutations in aberrant crypt foci and colonic tumors induced by azoxymethane in rats. Proceedings of the American Association for Cancer Research 38:467.
7. Caygill CP, Hill MJ. 1995. Fish, n-3 fatty acids and human colorectal and breast cancer mortality. Eur J Cancer Prev 4:329-332.
8. Caygill CPJ, Charland SL, Lippin JA. 1996. Fat, fish, fish oil, and cancer. Br J Cancer 74:159-164.
9. Craven RA, Pfanstial J, DeRubertis FR. 1987. Role of activation of protein kinase C in the stimulation of colonic epithelial proliferation and reactive oxygen formation by bile acids. J Clin Invest 79:532-541.
10. Davidson LA, Jiang YH, Derr JN, Aukema HM, Lupton JR, Chapkin RS. 1994. Protein kinase C isoforms in human and rat colonic mucosa. Arch Biochem Biophys 312:547-553.
11. Druckrey H. 1970. Production colonic carcinomas by 1,2-dilkylhydrazines and azoxyalkanes. In: Burdette WJ, editor. Carcinoma of the colon and antecedent epithelium. Springfield, IL: Charles C Thomas. p 267-272.
12. Dubois RN, Radhika A, Reddy BS, Entingh AJ. 1996. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 110:1259-1262.
13. Eberhart CE, DuBois RN. 1995. Eicosanoids and the gastrointestinal tract. Gastroenterology 109:285-301.
14. Eberhart CE, Coffey RJ, Radhika A, Giardello FM, Ferrenbach S, DuBois RN. 1994. Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183-88.
15. Elwell MR, McConnell ES. 1990. Small and large intestine. In: Boorman GA, Eustis SL, Elwell MR, Montgomery CA, Mackenzie WF, editors. Pathology of Fischer rat. San Diego, CA: Academic Press. p 43-61.
16. Fiala ES. 1977. Investigations into the metabolism and mechanism of action of the colon carcinogens 1,2-dimethylhydrazine and azoxymethane. Cancer 40:2436-2445.
17. Fiala ES, Sohn OS, Puz C, Czerniak R. 1987. Differential effects of 4-iodopyrazole and 3-methylpyrazole on the metabolic activation of methylazoxymethanol to a DNA methylating species by rat liver and rat colon mucosa in vivo. J Cancer Res Clin Oncol 113:145-150.
18. Forrester K, Almoguera C, Hand K, Grizzle WE, Perucho M. 1987. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 327:298-303.
19. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. 1994. Aspirin use and the risk for colorectal cancer and adenomas in male health professionals. Ann Intern Med 121:241-246.
20. Holt PR, Mokuolu AO, Distler P, Liu T, Reddy BS. 1996. Regional distribution of carcinogen-induced colon neoplasia in the rat. Nutr Cancer 25:129-135.
21. Huang MT, Deschner EE, Newmark HL, Wang ZY, Ferraro TN, Conney AH. 1992. Effect of dietary curcumin and ascorbylpalmitate on azoxymethane-induced colonic epithelial cell proliferation and focal areas of dysplasia. Cancer Lett 64:117.
22. Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA, Jothy S. 1995. Expression of prostaglandin G/H synthase-1 and-2 protein in human colon cancer. Cancer Res 55:2556-2559.
23. Kawamori T, Rao CV, Seibert K, Reddy BS. 1998. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 58:409-412.
24. Kawamori T, Lubet R, Steele VE, Kelloff GJ, Kaskey RB, Rao CV, Reddy BS. 1999. Chemopreventive effect of curcumin, a naturally-occurring antiinflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res 59:597-601.
25. Kune GA, Kune S, Watson LF. 1988. Colorectal cancer risk, chronic illness, operations and medications: case-control results form the Melbourne Colorectal Cancer Study. Cancer Res 48:4399-4404.
26. Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C, Duhamael O, Trousset M, Attali P. 1991. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 101:635-639.
27. Lengaver C, Kinzler KW, Vogelstein B. 1998. Genetic instabilities in human cancer. Nature 396:643-649.
28. Moser AR, Pitot HC, Dove WF. 1990. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247:322-324.
29. Narisawa T, Satoh M, Sano M, Takahashi T. 1998. Inhibition of initiation and promotion on N-methylnitrosourea-induced colon carcinogenesis in rats by non-steroidal anti-inflammatory agent indomethacin. J Jpn Surg Soc 99:362-367.
30. Nigro ND, Singh DV, Campbell RL, Pak MS. 1975. Effect of dietary beef fat on the intestinal tumor formation by azoxymethane in rats. J Natl Cancer Inst 54:439-442.
31. Oshima M, Takahashi M, Oshima H, Tsutsumi M, Yazawa K, Sugimura T. 1995. Effect of docosahexaenoic acid on intestinal polyp development in Apedelta716 knockout mice. Carcinogenesis 16:2605-2607.
32. Oshima M, Murai N, Kargman S, Arguello M, Luk P, Kwong E. 2001. Chemoprevention of intestinal polyposis in the Apedelta716 mouse by rofecoxib, a specific cyclooxygenase inhibitor. Cancer Res 61:1733-1740.
33. Pollard M, Luckert PH. 1984. Effect of piroxicam on primary intestinal tumors induced in rats by N-methylnitrosourea. Cancer Lett 25:117-121.
34. Potter JD, Steinmetz K. 1995. Vegetables, fruits and phytoestrogens as preventive agents. In: Stewart BW, McGregor D, Kleihues P, editors. Principles of chemoprevention. Lyon: International Agency for Research on Cancer Sci Publ 139:61.
35. Pretlow TP, O'Riordan MA, Pretlow TG, Stellato TA. 1992. Aberrant crypts in human colonic mucosa: putative preneoplastic lesions. J Cell Biochem 16G(suppl):55-62.
36. Rao CV, Reddy BS. 1993. Modulating effect of amount and types of dietary fat on ornithine decarboxylase, tyrosine protein kinase, and prostaglandins production during colon carcinogenesis. Carcinogenesis 14:1327-1333.
37. Rao CV, Simi B, Reddy BS. 1993. Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in rat colon. Carcinogenesis 14:2219-2225.
38. Rao CV, Rivenson A, Simi B, Reddy BS. 1995a. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally-occurring plant phenolic compound. Cancer Res 55:259-266.
39. Rao CV, Rivenson A, Simi B, Zang E, Kelloff G, Steele V, Reddy BS. 1995b. Chemoprevention of colon carcinogenesis by sulindac, a non-steroidal antiinflammatory agent. Cancer Res 55:1464-1472.
40. Rao CV, Simi B, Wynn T-T, Garr K, Reddy BS. 1996. Modulating effect of amount and types of dietary fat on colonic mucosal phospholipase A2, phosphatidylinositol-specific phospholipase C activities, and cyclooxygenase metabolite formation during different stages of colon tumor promotion in male F344 rats. Cancer Res 56:532-537.
41. Rao CV, Hirose Y, Indranie C, Reddy BS. 2001. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res 61:1927-1933.
42. Rao CV, Cooma I, Simi B, Manning PT, Connor JR, Reddy BS. 2002. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res 62:165-170.
43. Reddy BS. 1995. Nutritional factors and colon cancer. Crit Rev Food Sci Nutr 35:175-190.
44. Reddy BS. 2002. Carcinogen-induced colon cancer models for chemoprevention and nutritional studies. In: Teicher BA, editor. Tumor models in cancer research. Totowa, NJ: Humana Press. p 183-191.
45. Reddy BS, Maeura Y. 1984. Tumor promotion by dietary fat in azoxymethane-induced colon carcinogenesis in female F344 rats: influence of amount and sources of dietary fat. J Natl Cancer Inst 72:745-745.
46. Reddy BS, Maruyama H. 1986. Effect of different levels of dietary corn oil and lard during the initiation phase of colon carcinogenesis in male F344 rats. J Natl Cancer Inst 77:815-822.
47. Reddy BS, Rao CV. 2003a. Role of synthetic and naturally occurring cyclooxygenase inhibitors in colon cancer prevention. In: Harris RE, editor. COX-2 blockade in cancer prevention and therapy. Totowa, NJ: Humana Press. p 71-83.
48. Reddy BS, Rao CV. 2003b. Chemoprevention of cancer by curcumin. In: Kelloff GJ, Hawk ET, Segman CC, editors. Cancer Chemoprevention. Promising Cancer Chemopreventive Agents, Vol. 1. Totowa, NJ: Humana Press (in press).
49. Reddy BS, Sugie S. 1988. Effect of different levels of omega-3 and omega-6 fatty acids on azoxymethane-induced colon carcinogenesis in F 344 rats. Cancer Res 48:6642-6847.
50. Reddy BS, Narisawa T, Maronpot R, Weisburger J. 1975. Animal models for the study of dietary factors and cancer of the large bowel. Cancer Res 35:3421-3426.
51. Reddy BS, Watanabe K, Weisburger JH, Wynder EL. 1977. Promoting effect of bile acids in colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res 37:3238-3242.
52. Reddy BS, Maruyama H, Kelloff G. 1987. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal anti-inflammatory drug, during different stages of rat colon tumor development. Cancer Res 47:5340-5346.
53. Reddy BS, Nayini J, Tokumo K, Rigotty J, Zang E, Kelloff G. 1990. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug, with D,L-alpha- difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. Cancer Res 50:2562-2568.
54. Reddy BS, Rao CV, Rivenson A, Kelloff GJ. 1993. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis (Lond.) 14:1493-1497.
55. Reddy BS, Rao CV, Seibert K. 1996. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon cancer. Cancer Res 56:4566-4569.
56. Reddy BS, Wang C-X, Samaha H, Lubet R, Steele V, Kelloff G, Rao CV. 1997. Chemoprevention of colon carcinogenesis by dietary perillyl alcohol. Cancer Res 57:420-425.
57. Reddy B, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV. 2000. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Cancer Res 60:293-297.
58. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro S. 1991. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large bowel cancer. J Natl Cancer Inst 83:355-358.
59. Samaha S, Kelloff GJ, Steele V, Rao CV, Reddy BS. 1997. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res 57:1301-1305.
60. Shamsuddin AKM. 1984a. Comparative studies of primary, metastatic and transplanted adenocarcinomas of Fischer 344 rats. J Submicrosc Cytol 16:697-704.
61. Shamsuddin AKM. 1984b. Mucinous colloid adenocarcinoma of colon in Fisher-344 rats. Light microscopy, histochemistry and ultrastructure. J Submicrosc Cytol 16:327-339.
62. Singh J, Kulkarni N, Kelloff G, Reddy BS. 1994. Modulation of azoxymethane-induced mutational activation of ras protooncogenes by chemopreventive agents in colon carcinogenesis. Carcinogenesis 15:1317-1323.
63. Singh J, Rivenson A, Tomita M, Shimamura S, Ishibasi N, Reddy BS. 1997. Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 18:833-841.
64. Sohn OS, Ishizaki H, Yang CS, Fiala ES. 1991. Metabolism of azyoxymethane, methylazoxymethanol and N-nitrosodimethylamine by cytochrome P450IIE1. Carcinogenesis (Lond) 12:127-131.
65. Tahahashi M, Fukuda K, Sugimura T, Wakabayashi K. 1998. β-Catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res 58:42-46.
66. Taketo MM. 1998. Cyclooxygenase-2 inhibitors in tumorigenesis (Part I). J Natl Cancer Inst 90:1529-1536.
67. Thun MH, Namboodiri MM, Heath CW. 1991. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325:1593-1596.
68. Tsujii M, DuBois RN. 1995. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83:493-501.
69. Whelan J, McEntee MF. 2003. Nonsteroidal anti-inflammatory drugs, prostaglandins, and APC-driven intestinal tumorigenesis. In: Harris RE, editor. COX-2 blockade in cancer prevention and therapy. Totowa, NJ: Humana Press. p 117-145.
70. World Cancer Research Fund and American Institute for Cancer Research. 1997. Panel on food. nutrition and the prevention of cancer. Washington, DC: American Institute for Cancer Research. p 228-229.
71. Yamada Y, Mori H. 2003. Pre-cancerous lesions for colorectal cancers in rodent: a new concept. Carcinogenesis 24:1015-1019.
72. Yang K, Fan K, Newmark H, Leung D, Lipkin M, Steele VE, Kelloff GJ. 1996. Cytokeratin, lectin, and acidic mucin modulation in differentiating colonic epithelial cells of mice after feeding Western-style diets. Cancer Res 56:4644-4648.
73. Zeng Y, Kramer P, Olsen G, Lubet RA, Steele VE, Kelloff GJ, Pereira MA. 1997. Prevention by retinoids of azoxymethane-induced tumors and aberrant crypt foci and their modulation of cell proliferation in the colon of rats. Carcinogenesis 18:2119-2125.